Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Nieder

Showing results (41-50 of 301) with videos related to

Pageof 31
Sort By:
Scandinavian Journal of Urology|February 25, 2020
Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care settingCarsten Nieder, Astrid Dalhaug, Ellinor Haukland
Cureus|February 12, 2020
Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival OutcomeCarsten Nieder, Bård Mannsåker, Rosalba Yobuta
Anticancer Research|January 9, 2021
Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM ScoreCarsten Nieder, BÅrd MannsÅker, Rosalba Yobuta
Cureus|February 17, 2022
Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory AnalysisCarsten Nieder, Bård Mannsåker, Rosalba Yobuta
Journal of Clinical Medicine Research|April 26, 2019
External Validation of the LabBM Score in Patients With Brain MetastasesCarsten Nieder, Astrid Dalhaug, Adam Pawinski
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 1, 2023
Percent of remaining life on palliative radiation treatment: solely a function of fractionation?Carsten Nieder, Bård Mannsåker, Astrid Dalhaug
Cureus|May 14, 2020
LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal RadiotherapyCarsten Nieder, Rosalba Yobuta, Bård Mannsåker
In Vivo (Athens, Greece)|March 4, 2022
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain InvolvementCarsten Nieder, Astrid Dalhaug, Bård Mannsåker
Anticancer Research|February 27, 2022
Independent External Validation of the METSSS Model Predicting Survival After Palliative RadiotherapyCarsten Nieder, Bard Mannsåker, Rosalba Yobuta
Journal of Clinical Medicine Research|February 26, 2020
Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction RadiotherapyCarsten Nieder, Bard Mannsaker, Astrid Dalhaug
Pageof 31

Showing results (41-50 of 301) with videos related to

Sort By:
Pageof 31
Scandinavian Journal of Urology|February 25, 2020
Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care settingCarsten Nieder, Astrid Dalhaug, Ellinor Haukland
Cureus|February 12, 2020
Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival OutcomeCarsten Nieder, Bård Mannsåker, Rosalba Yobuta
Anticancer Research|January 9, 2021
Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM ScoreCarsten Nieder, BÅrd MannsÅker, Rosalba Yobuta
Cureus|February 17, 2022
Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory AnalysisCarsten Nieder, Bård Mannsåker, Rosalba Yobuta
Journal of Clinical Medicine Research|April 26, 2019
External Validation of the LabBM Score in Patients With Brain MetastasesCarsten Nieder, Astrid Dalhaug, Adam Pawinski
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 1, 2023
Percent of remaining life on palliative radiation treatment: solely a function of fractionation?Carsten Nieder, Bård Mannsåker, Astrid Dalhaug
Cureus|May 14, 2020
LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal RadiotherapyCarsten Nieder, Rosalba Yobuta, Bård Mannsåker
In Vivo (Athens, Greece)|March 4, 2022
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain InvolvementCarsten Nieder, Astrid Dalhaug, Bård Mannsåker
Anticancer Research|February 27, 2022
Independent External Validation of the METSSS Model Predicting Survival After Palliative RadiotherapyCarsten Nieder, Bard Mannsåker, Rosalba Yobuta
Journal of Clinical Medicine Research|February 26, 2020
Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction RadiotherapyCarsten Nieder, Bard Mannsaker, Astrid Dalhaug
Pageof 31